---
figid: PMC2898136__nihms-210716-f0003
figtitle: Eicosanoids and cancer
organisms:
- Mus musculus
- Rattus norvegicus
- Cricetus cricetus
- Homo sapiens
- Bos taurus
- Gallus gallus
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Bos taurus
- Gallus gallus
- Drosophila melanogaster
pmcid: PMC2898136
filename: nihms-210716-f0003.jpg
figlink: /pmc/articles/PMC2898136/figure/F3/
number: F3
caption: Multiple cellular signalling pathways mediate the effects of prostaglandin
  E2 (PGE2) and leukotriene B4 (LTB4) on the regulation of epithelial tumour cell
  proliferation, survival, and migration and invasion. PGE2 stimulates cell proliferation
  through multiple cascades in both colorectal cancer (CRC) and non-small-cell lung
  cancer cells. PGE2 also induces cell proliferation through a glycogen synthase kinase-3β
  (GSK3β)–β-catenin (β-cat) pathway in CRC cells or by the upregulation of aromatase
  in breast cancer cells. PGE2 inhibition of GSK3β reduces β-catenin phosphorylation
  and thereby prevents its degradation, leading to accumulation, nuclear translocation
  and functional activity of β-catenin. PGE2 promotes CRC cell survival by activating
  a PI3K–Akt– peroxisome proliferator-activated receptor-δ (PPARδ) cascade in vitro
  and in vivo. In addition, PGE2 induces CRC cell migration and invasion through β-arrestin-1–SRC–epidermal
  growth factor receptor (EGFR)–PI3K–Akt signalling in vitro and in vivo. PGE2 transactivation
  of EGFR also depends on the extracellular release of an EGF-like ligand in CRC cell
  lines and a normal gastric epithelial cell line. PGE2 also induces cell migration
  and invasion through an Erk–ETS1–matrix metalloproteinase 2 (MMP2) cascade in pancreatic
  cancer cell lines or through the upregulation of C-C chemokine receptor 7 (CCR7)
  in breast cancer cell lines. LTB4 stimulates cell proliferation and promotes cell
  survival through a BLT1–Erk pathway in CRC cell lines or through both Mek–Erk and
  PI3K–Akt pathways in human pancreatic cancer cell lines. P, phosphorylation.
papertitle: Eicosanoids and cancer.
reftext: Dingzhi Wang, et al. Nat Rev Cancer. ;10(3):181-193.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9708354
figid_alias: PMC2898136__F3
figtype: Figure
redirect_from: /figures/PMC2898136__F3
ndex: 8949d787-dec6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2898136__nihms-210716-f0003.html
  '@type': Dataset
  description: Multiple cellular signalling pathways mediate the effects of prostaglandin
    E2 (PGE2) and leukotriene B4 (LTB4) on the regulation of epithelial tumour cell
    proliferation, survival, and migration and invasion. PGE2 stimulates cell proliferation
    through multiple cascades in both colorectal cancer (CRC) and non-small-cell lung
    cancer cells. PGE2 also induces cell proliferation through a glycogen synthase
    kinase-3β (GSK3β)–β-catenin (β-cat) pathway in CRC cells or by the upregulation
    of aromatase in breast cancer cells. PGE2 inhibition of GSK3β reduces β-catenin
    phosphorylation and thereby prevents its degradation, leading to accumulation,
    nuclear translocation and functional activity of β-catenin. PGE2 promotes CRC
    cell survival by activating a PI3K–Akt– peroxisome proliferator-activated receptor-δ
    (PPARδ) cascade in vitro and in vivo. In addition, PGE2 induces CRC cell migration
    and invasion through β-arrestin-1–SRC–epidermal growth factor receptor (EGFR)–PI3K–Akt
    signalling in vitro and in vivo. PGE2 transactivation of EGFR also depends on
    the extracellular release of an EGF-like ligand in CRC cell lines and a normal
    gastric epithelial cell line. PGE2 also induces cell migration and invasion through
    an Erk–ETS1–matrix metalloproteinase 2 (MMP2) cascade in pancreatic cancer cell
    lines or through the upregulation of C-C chemokine receptor 7 (CCR7) in breast
    cancer cell lines. LTB4 stimulates cell proliferation and promotes cell survival
    through a BLT1–Erk pathway in CRC cell lines or through both Mek–Erk and PI3K–Akt
    pathways in human pancreatic cancer cell lines. P, phosphorylation.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Egfr
  - Src
  - Gsk3b
  - Mdk
  - Pik3r1
  - ras
  - Hras
  - Kras
  - Rem1
  - Zhx2
  - Akt1
  - Ephb2
  - Mapk1
  - Ccr7
  - Mmp2
  - EGFR
  - SRC
  - FGR
  - FYN
  - YES1
  - GSK3B
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - CCR7
  - MMP2
  - Pik3cg
  - Cyp19a1
  - Ephb1
  - GSK3A
  - Src42A
  - Csk
  - Src64B
  - Arr2
  - sgg
  - Axn
  - gskt
  - Dsor1
  - Mtk
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Ras64B
  - Ras85D
  - Raf
  - Akt
  - Erk7
  - rl
  - arm
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - PGE
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
---
